How To Exempt From Reporting And Recordkeeping Requirements For Tv And Computer Monitors With Cathode Ray Tubes



Similar documents
Contains Nonbinding Recommendations

Guidance for Industry. Further Amendments to General Regulations of the Food and Drug Administration to Incorporate Tobacco Products

Medical Device Data Systems, Medical Image Storage Devices, and Medical Image Communications Devices

Guidance for Industry

U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) September 2009 OTC

Guidance for Industry

Guidance for Industry and Investigators Safety Reporting Requirements for INDs and BA/BE Studies- Small Entity Compliance Guide

U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) March 2006 Compliance

Unique Device Identifier System: Frequently Asked Questions, Vol. 1 Guidance for Industry and Food and Drug Administration Staff

FINAL GUIDANCE. For questions on the content of this guidance, contact Advisory Committee Oversight and Management Staff, at

Guidance for Industry and FDA Staff Tonometers - Premarket Notification [510(k)] Submissions

October 28, Cavex Holland Bv Mr. Richard Woortman Manager Technical Services Fustweg 5 Haarlem, 2031CJ The NETHERLANDS

General Wellness: Policy for Low Risk Devices. Draft Guidance for Industry and Food and Drug Administration Staff

Determination of Regulatory Review Period for Purposes of Patent Extension; XARELTO

Guidance for Industry. 21 CFR Part 11; Electronic. Records; Electronic Signatures. Time Stamps

Information Sheet Guidance For IRBs, Clinical Investigators, and Sponsors

DSCSA Implementation: Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers

Determination of Regulatory Review Period for Purposes of Patent Extension;

Guidance for Clinical Investigators, Sponsors, and IRBs

Use of Electronic Health Record Data in Clinical Investigations

May 7, Tactile Systems Technology Inc Daniel Chase V.P. Engineering & Operations 1331 Tyler St NE Minneapolis, Minnesota 55413

Guidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff

Guidance for Industry

Guidance for Industry

Guidance for Industry

Guidance for Industry

Guidance for Industry

Guidance for Industry and Food and Drug Administration Staff

Document issued on: December 2, The draft of this document was issued on March 11, Contains Nonbinding Recommendations

February 5, Dear Kristin Pabst,

DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.

Guidance for Industry

Information Sheet Guidance For IRBs, Clinical Investigators, and Sponsors

Guidance for Industry Tablet Scoring: Nomenclature, Labeling, and Data for Evaluation

DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.

January 12, Dear Amy Yang:

Recommended Warning for Overthe-Counter. Containing Drug Products and Labeling Statements Regarding Serious Skin Reactions

Guidance for Industry

0 EC V-,) 133 Lj9a

Guidance for Clinical Investigators, Industry, and FDA Staff Financial Disclosure by Clinical Investigators

How To Validate Software

November 20, Vascular Flow Technologies Ltd. Edwin Lindsay VP of QA/RA Prospect Business Centre, Gemini Cresent Dundee DD2 1TY United Kingdom

Guidance for Industry

Guidance for IRBs, Clinical Investigators, and Sponsors. Considerations When Transferring Clinical Investigation Oversight to Another IRB

Guidance for Industry Classifying Resubmissions in Response to Action Letters

Guidance for Industry 180-Day Exclusivity When Multiple ANDAs Are Submitted on the Same Day

August 21, TCM Associates Ltd Mr. Iain Alligan Technical Director 3 Hillgrove Business Park Nazeing Road Essex EN9 2HB United Kingdom

Refuse to Accept Policy for 510(k)s. Guidance for Industry and Food and Drug Administration Staff

Guidance Medication Guides Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS)

Guidance for Industry. Required Warnings for Cigarette Packages and Advertisements

Guidance for Industry Direct-to-Consumer Television Advertisements FDAAA DTC Television Ad Pre- Dissemination Review Program

Use of Electronic Informed Consent in Clinical Investigations Questions and Answers Guidance for Industry

Guidance for Industry

Guidance for Industry. 21 CFR Part 11; Electronic Records; Electronic Signatures. Electronic Copies of Electronic Records

DICOM Grid, Inc. January 25, Senior Consultant Biologics Consulting Group, Inc. 400 N. Washington Street, Suite 100 ALEXANDRIA VA 22314

Guidance for Industry Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices

Ad-tech Medical Instrument Corporation. Principal Consultant Quality & Regulatory Associates, LLC. 800 Levanger Lane. Stoughton, Wisconsin 53589

Document issued on: May 11, 2005

Guidance for Sponsors, Investigators, and Institutional Review Boards. Questions and Answers on Informed Consent Elements, 21 CFR 50.

Guidance for Industry Certification Process for Designated Medical Gases

Registration of Human Drug Compounding Outsourcing Facilities Under Section 503B of the FD&C Act. Guidance for Industry

Guidance for Industry and FDA Staff Commercially Distributed Analyte Specific Reagents (ASRs): Frequently Asked Questions

SECTION 5 BARDEX TEMPERATURE-SENSING FOLEY CATHETER 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS INFORMATION

DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.

Brainreader ApS February 4, 2015 C/O Mette Munch QA Consultant Skagenvej 21 Egaa, 8250 DENMARK

February 22, Life Spine, Incorporated Mr. Randy Lewis General Manager 2401 West Hassell Road, Suite 1535 Hoffman Estates, Illinois 60169

GE Healthcare MAR

Ultimate Concepts Inc.

Custom Device Exemption. Draft Guidance for Industry and Food and Drug Administration Staff

March 3, Dear Ms. Alice Gong,

Guidance for Industry

The Mammography Quality Standards Act Final Regulations Document #1

Guidance for Industry Bar Code Label Requirements Questions and Answers

Guidance for Industry ANDA Submissions Amendments and Easily Correctable Deficiencies Under GDUFA

May 5, Dear Mr. Courtney:

Simpler Implant Solutions Inc Arbutus St. Vancouver, BC V6i 3Y9. haroldbergmanl~ogmail.com Telephone Fax K080115

Unique Device Identification System: Small Entity Compliance Guide Guidance for Industry and Food and Drug Administration Staff

Guidance for Industry Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification

The draft of this document issued on December 27, 2011.

UNITED STATES OF AMERICA BEFORE THE FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES

JUN 2 6 butt. EkoSonicTM Endovascular System with Rapid Pulse Modulation

Guidance for Industry

Transcription:

Guidance for Industry and FDA Staff Exemption from Certain Reporting and Recordkeeping Requirements for Television Receivers and Computer Monitors with Cathode Ray Tubes Document issued on October 20, 2006 For questions regarding this document contact George Kraus at 301-796-5866 or George.Kraus@fda.hhs.gov. U.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Electronic Product Branch Division of Mammography Quality and Radiation Programs Office of Communication, Education, and Radiation Programs 1

Public Comment Preface Written comments and suggestions may be submitted at any time for Agency consideration to the Division of Dockets Management, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD, 20852. When submitting comments, please refer to the exact title of this guidance document. Comments may not be acted upon by the Agency until the document is next revised or updated. Additional Copies Additional copies are available from the Internet at: http://www.fda.gov/cdrh/comp/eprc.html. You may also send an e-mail request to dsmica@fda.hhs.gov to receive an electronic copy of the guidance or send a fax request to 301-847-8149 to receive a hard copy. Please use the document number (1612) to identify the guidance you are requesting. 2

Guidance for Industry and FDA Staff Exemption from Reporting and Recordkeeping Requirements for Television Receivers and Computer Monitors with Cathode Ray Tubes This guidance represents the Food and Drug Administration's (FDA's) current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. You can use an alternative approach if the approach satisfies the requirements of the applicable statutes and regulations. If you want to discuss an alternative approach, contact the FDA staff responsible for implementing this guidance. If you cannot identify the appropriate FDA staff, call the appropriate number listed on the title page of this guidance. Introduction Under Title 21 of the Code of Federal Regulations 1002.50 (21 CFR 1002.50), FDA may exempt manufacturers of electronic products from reporting and recordkeeping requirements subject to any conditions necessary to protect the public health. This guidance provides notification of FDA s exemption of television receivers and computer monitors containing cathode ray tubes (CRT s) from certain reporting and recordkeeping requirements because of the low risk of exposure to x-radiation and minimal risk to public health. FDA's guidance documents, including this guidance, do not establish legally enforceable responsibilities. Instead, guidances describe the Agency's current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited. The use of the word should in Agency guidances means that something is suggested or recommended, but not required. 3

The Least Burdensome Approach We believe we should consider the least burdensome approach in all areas of medical device and electronic product regulation. This guidance reflects our careful review of the relevant scientific and legal requirements and what we believe is the least burdensome way for you to comply with those requirements. However, if you believe that an alternative approach would be less burdensome, please contact us so we can consider your point of view. You may send your written comments to the contact person listed in the preface to this guidance or to the CDRH Ombudsman. Comprehensive information on CDRH's Ombudsman, including ways to contact him, can be found on the Internet at http://www.fda.gov/cdrh/ombudsman/. Issue All manufacturers of electronic products, which include all television receivers and computer monitors containing CRT s, must submit product and supplemental reports according to 21 CFR 1002.10 and 1002.11, abbreviated reports according to 21 CFR 1002.12, and annual reports according to 21 CFR 1002.13. According to 21 CFR 1002.10, product reports must describe the test methods and procedures to ensure product safety and compliance with the Federal performance standard for television receivers. FDA is now reducing the amount of required reporting and recordkeeping information as well as testing for television receiver and computer monitor products containing CRT s because of the low risk of exposure to x-radiation and minimal risk to public health. Manufacturers should refer to the Reporting and Compliance Guide for Television Products (http://www.fda.gov/cdrh/radhlth/pdf/tvvrptgd.pdf) which contains instructions and format for submitting hard copy reports to FDA. Guidance 1. Why is FDA granting this exemption? This exemption reduces the regulatory burden on manufacturers of television receivers and computer monitors containing CRT s without compromising the public health. 2. What products does the exemption cover? The exemption covers all television receivers and computer monitors containing CRT s. 4

3. What reporting requirements are reduced by this exemption? Manufacturers of television receivers and computer monitors containing CRT s are exempted from o All product reports except for the first product report as required by 21 CFR 1002.10 o All supplemental reports required by 21 CFR 1002.11 o All abbreviated reports except for the first abbreviated report as required by 21 CFR 1002.12 o Quarterly updates to annual reports as required by 21 CFR 1002.13(c) Part 7.8 of the Reporting and Compliance Guide for Television Products (http://www.fda.gov/cdrh/radhlth/pdf/tvvrptgd.pdf ) is no longer applicable provided the conditions for use in question 5 are met. 4. What recordkeeping and testing requirements are reduced by this exemption? Manufacturers of television receivers and computer monitors containing CRT s are exempted from o Certain recordkeeping requirements described in 21 CFR 1002.30 Under 1002.30(a)(2), manufacturers do not have to conduct testing and maintain records for Phase III final production testing for television receivers or computer monitors containing CRT s. Under 1002.30(a)(3), manufacturers do not have to conduct testing and maintain records for life or aging effects. o Certain recordkeeping requirements described in 21 CFR 1002.30(b), 1002.40, and 1002.41 Under 21 CFR 1002.30(b), manufacturers do not have to maintain distribution records to distributors and dealers. Under 21 CFR 1002.40 and 1002.41, distributors and dealers do not have to maintain distribution records of purchasers. provided the conditions for use in question 5 are met. 5. What are the conditions for use of the exemption? The manufacturer must test and certify that the television receivers and computer monitors containing CRT s comply with the Federal performance standards contained in 21 CFR 1020.10. 5

For each model family being certified, manufacturers should maintain records referred to in Part 8C of the Reporting and Compliance Guide for Television Products (http://www.fda.gov/cdrh/radhlth/pdf/tvvrptgd.pdf) which describes the following components of engineering analysis: Worst-tolerance chassis Design-center chassis Worst-component failure Phase III test conditions according to 21 CFR 1020.10c(3)(iii) The manufacturer must file a single product report and/or a single abbreviated report for television receiver and computer monitor products containing CRT s, regardless of how many different model families are produced after the initial filing. 6. What requirements are not included in this exemption? The manufacturer must continue to submit annual reports required by 21 CFR 1002.13, which contain listings of all products tested and certified during the reporting year. The listing must include all television receivers and computer monitors containing CRT s that were distributed into United States commerce during the reporting period, including information that previously would have been reported in a quarterly update to the annual report. Manufacturers must continue to meet all other applicable requirements, including o 21 CFR 1002.20 (Reporting of Accidental Radiation Occurrences) o 21 CFR 1002.30(a) and 1002.31 (Manufacturer's Records) o 21 CFR 1003 (Notification of Defects or Failure to Comply) o 21 CFR 1004 (Repurchase, Repairs, or Replacement of Electronic Products). 7. Can the Center revoke this exemption? Yes. FDA reserves the right to request additional information from the manufacturer concerning these products or full reports and recordkeeping if FDA determines this to be necessary in keeping with the intent of the U.S. Federal Food, Drug and Cosmetic Act, Subchapter V, Subchapter C Electronic Product Radiation Control. This would be the case if FDA has reason to believe that the manufacturer is not abiding by the conditions of the exemption. Getting More Information 6

You can get more information about our requirements for television receivers and computer monitors from our electronic product radiation control web page at http://www.fda.gov/cdrh/comp/eprc.html. If you have questions about this guidance, contact George Kraus, Center for Devices and Radiological Health (HFZ-240), Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993 or George.Kraus@fda.hhs.gov. 7